Telo Genomics Corp. (TSXV:TELO)
Canada · Delayed Price · Currency is CAD 0.0400
0.00 (0.00%)
Sep 4, 2026, 2:30 PM EST
Telo Genomics Cash Flow Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -2.34 | -2.72 | -2.71 | -2.82 | -2.11 | -1.07 |
Depreciation & Amortization | 0.05 | 0.01 | 0.04 | 0.03 | 0.06 | 0.06 |
Loss (Gain) From Sale of Assets | - | - | 0 | - | - | - |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | - | - | - | - |
Stock-Based Compensation | 0.14 | 0.27 | 0.06 | 0.16 | 0.15 | 0.14 |
Other Operating Activities | 0.02 | 0.05 | -0.01 | - | - | -0.19 |
Change in Accounts Receivable | -0 | 0 | 0.03 | -0.03 | 0.06 | -0.05 |
Change in Accounts Payable | 0.6 | 0.02 | 0.11 | 0.07 | 0.08 | -0.04 |
Change in Other Net Operating Assets | 0.2 | 0.02 | 0.01 | -0.05 | -0.03 | 0.04 |
Operating Cash Flow | -1.3 | -2.33 | -2.46 | -2.63 | -1.79 | -1.1 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -0.02 | -0 | -0.01 | -0.07 | -0.03 | -0.01 |
Other Investing Activities | -0.21 | - | - | - | - | - |
Investing Cash Flow | -0.22 | -0 | -0.01 | -0.07 | -0.03 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt Issued | 1.25 | - | - | - | - | - |
Short-Term Debt Repaid | - | - | - | - | - | -0.02 |
Long-Term Debt Repaid | - | - | -0.02 | -0.01 | - | - |
Total Debt Repaid | - | - | -0.02 | -0.01 | - | -0.02 |
Net Debt Issued (Repaid) | 1.25 | - | -0.02 | -0.01 | - | -0.02 |
Issuance of Common Stock | - | 2.55 | 0.65 | 2.89 | 0.89 | 3.99 |
Other Financing Activities | - | -0.22 | -0.04 | -0.21 | -0.02 | -0.15 |
Financing Cash Flow | 1.25 | 2.33 | 0.59 | 2.68 | 0.88 | 3.83 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Cash Flow | -0.27 | -0.01 | -1.88 | -0.02 | -0.94 | 2.72 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -1.32 | -2.33 | -2.46 | -2.7 | -1.82 | -1.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.04 | -0.03 | -0.02 |
Levered Free Cash Flow | -0.61 | -1.37 | -1.46 | -1.62 | -1.03 | -0.84 |
Unlevered Free Cash Flow | -0.56 | -1.37 | -1.46 | -1.62 | -1.03 | -0.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Change in Working Capital | 0.8 | 0.04 | 0.16 | -0 | 0.11 | -0.05 |